IT7823389A0 - NEW 5-IMINO-4-HYDROXYMETHYL-3-ISOXAZOLES WITH ANTI-CANCER ACTIVITY. - Google Patents

NEW 5-IMINO-4-HYDROXYMETHYL-3-ISOXAZOLES WITH ANTI-CANCER ACTIVITY.

Info

Publication number
IT7823389A0
IT7823389A0 IT7823389A IT2338978A IT7823389A0 IT 7823389 A0 IT7823389 A0 IT 7823389A0 IT 7823389 A IT7823389 A IT 7823389A IT 2338978 A IT2338978 A IT 2338978A IT 7823389 A0 IT7823389 A0 IT 7823389A0
Authority
IT
Italy
Prior art keywords
isoxazoles
imino
hydroxymethyl
new
cancer activity
Prior art date
Application number
IT7823389A
Other languages
Italian (it)
Other versions
IT1098214B (en
Inventor
Palamidessi Giorgio
Zarini Franco
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Priority to IT23389/78A priority Critical patent/IT1098214B/en
Publication of IT7823389A0 publication Critical patent/IT7823389A0/en
Priority to GB7913530A priority patent/GB2020650B/en
Priority to JP4891479A priority patent/JPS54148780A/en
Priority to DE19792919275 priority patent/DE2919275A1/en
Priority to BE0/195161A priority patent/BE876248A/en
Application granted granted Critical
Publication of IT1098214B publication Critical patent/IT1098214B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
IT23389/78A 1978-05-15 1978-05-15 5-IMINO-4-IDROSSIMETIL-3-ISOSSAZOLI GIFTS FOR ANTI-TUMOR ACTIVITY IT1098214B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT23389/78A IT1098214B (en) 1978-05-15 1978-05-15 5-IMINO-4-IDROSSIMETIL-3-ISOSSAZOLI GIFTS FOR ANTI-TUMOR ACTIVITY
GB7913530A GB2020650B (en) 1978-05-15 1979-04-18 5-imino-4-hydroxymethyl-3-isoxazolidones having antitumouractivity
JP4891479A JPS54148780A (en) 1978-05-15 1979-04-19 Antiitumor active novel 55iminoo44hydroxymethyll 33isooxazolidones
DE19792919275 DE2919275A1 (en) 1978-05-15 1979-05-12 NEW 5-IMINO-4-HYDROXYMETHYL-3-ISOXAZOLIDONE WITH ANTITUMOR EFFECT
BE0/195161A BE876248A (en) 1978-05-15 1979-05-14 5-IMINO-4-HYDROXYMETHYL-3-ISOXAZOLIDONES DERIVATIVES WITH ANTI-TUMOR ACTIVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23389/78A IT1098214B (en) 1978-05-15 1978-05-15 5-IMINO-4-IDROSSIMETIL-3-ISOSSAZOLI GIFTS FOR ANTI-TUMOR ACTIVITY

Publications (2)

Publication Number Publication Date
IT7823389A0 true IT7823389A0 (en) 1978-05-15
IT1098214B IT1098214B (en) 1985-09-07

Family

ID=11206641

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23389/78A IT1098214B (en) 1978-05-15 1978-05-15 5-IMINO-4-IDROSSIMETIL-3-ISOSSAZOLI GIFTS FOR ANTI-TUMOR ACTIVITY

Country Status (5)

Country Link
JP (1) JPS54148780A (en)
BE (1) BE876248A (en)
DE (1) DE2919275A1 (en)
GB (1) GB2020650B (en)
IT (1) IT1098214B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04122588U (en) * 1991-04-19 1992-11-04 株式会社野沢製作所 work trolley

Also Published As

Publication number Publication date
DE2919275A1 (en) 1979-11-22
BE876248A (en) 1979-11-14
IT1098214B (en) 1985-09-07
GB2020650A (en) 1979-11-21
GB2020650B (en) 1982-07-28
JPS54148780A (en) 1979-11-21

Similar Documents

Publication Publication Date Title
IT7928464A0 (en) PHARMACEUTICAL COMPOSITION HAVING ANTI-CANCER ACTIVITY.
ES252970Y (en) CATAMENIAL ABSORVING STRUCTURE.
NL7903029A (en) 2'DEOXY-5- (2-HALOGENVINYL) -URIDINES.
IT7825232A0 (en) CORNER STRUCTURE.
IT1193190B (en) 2,3,4,5-TETRAIDRO-1H-3-BENZAZEPINE MERCAPTO-REPLACED
NL7808373A (en) "BREAKWATER".
NO153847C (en) 2,4,4-trichloro-4-FORMYL-butyronitrile.
FI793663A (en) 1,2,4,5-TETRA-ALKYL-4-ARYLPIPERIDINER
NL7904540A (en) IMPROVED DIAPER WITH IMPROVED TOP.
SE7803411L (en) 2,6-DIALCOXIBENZAMIDES
IT8020808A0 (en) SPEED REDUCER WITH REGULATED START.
IT7924708A0 (en) COMPENSATOR.
IT1207584B (en) FRICTION RESISTANT CATALYSTS.
ATA457479A (en) STABILIZED 1,1,1-TRICHLORAETHANE
NL7901095A (en) COMPENSATOR.
IT1096333B (en) 1,2,4-TRIAZOLIDIN-3-ONI E-TIONI
ATA457579A (en) STABILIZED 1,1,1-TRICHLORAETHANE
IT7823389A0 (en) NEW 5-IMINO-4-HYDROXYMETHYL-3-ISOXAZOLES WITH ANTI-CANCER ACTIVITY.
NL7900005A (en) 11-ALKANOYL-4 "-DESOXY-4" -ISONITRILO-OLEANDOMYCIN-DERIBARES.
IT1114719B (en) 2 3-DIIDRO-4H-1-BENZOPYRAN-4-ONE O-CARBAMOYLOXY WITH PHARMACOLOGICAL ACTIVITY AS GASTRIC ANTI-SECRETING AGENTS
IT7823152A0 (en) NEW ANTI-CANCER DEOXYANTRACYCLINES.
NL7902733A (en) CONSTRUCTION.
ES242734Y (en) NOTEBOOK.
FI791080A (en) 4,6-dihalo-steroids
FI791139A (en) NYTT FRAMSTAELLNINGSFOERFARANDE AV 4-SUBSTITUERADE 1,2-DIFENYL-3,5-DIOXOPYRAZOLIDINER